Literature DB >> 18439462

Juvenile nasopharyngeal angiofibroma: evaluation and surgical management of advanced disease.

Giovanni Danesi1, Davide T Panciera, Richard J Harvey, Cristina Agostinis.   

Abstract

OBJECTIVE: Evaluate preoperative imaging in predicting operative stage. Describe the outcomes in surgically treated juvenile nasopharyngeal angiofibroma (JNA) with the influence of middle cranial fossa, carotid, or dural involvement on recurrence. STUDY
DESIGN: Retrospective cohort of surgically treated patients with JNA. SUBJECTS AND METHODS: Eighty-five patients from a regional Italian referral center were assessed for recurrence, radiologic, and operative staging. High risk areas involved were recorded at surgery.
RESULTS: Recurrence for advanced disease (IIIb+) was 18.2% (6 of 33) and 15.3% (13 of 85) overall. Preoperative staging poorly correlated with operative stage (P = 0.15). No single high risk area was predictive for recurrence, but the absence of any risk factor was associated with a favorable outcome (P < 0.01).
CONCLUSION: Dural involvement by tumor is rare and imaging may overstage disease. Anterior access, endoscopic or open, is sufficient to address intracranial involvement. When an open approach is used, a midface degloving technique affords excellent exposure even for advanced disease. Lateral approaches with their associated morbidity can be reserved for selected recurrent disease.

Entities:  

Mesh:

Year:  2008        PMID: 18439462     DOI: 10.1016/j.otohns.2008.01.011

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

Review 1.  Juvenile Angiofibroma: Current Management Strategies.

Authors:  Ahmad Safadi; Alberto Schreiber; Dan M Fliss; Piero Nicolai
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

2.  Preoperative Embolization to Improve the Surgical Management and Outcome of Juvenile Nasopharyngeal Angiofibroma (JNA) in a Single Center: 10-Year Experience.

Authors:  J Lutz; M Holtmannspötter; W Flatz; A Meier-Bender; A Berghaus; H Brückmann; P Zengel
Journal:  Clin Neuroradiol       Date:  2015-01-29       Impact factor: 3.649

Review 3.  Endoscopic treatment of juvenile nasopharyngeal angiofibromas: our experience and review of the literature.

Authors:  G Fyrmpas; I Konstantinidis; J Constantinidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-26       Impact factor: 2.503

Review 4.  The role of radiology in head and neck tumours in children.

Authors:  Claire Lloyd; Kieran McHugh
Journal:  Cancer Imaging       Date:  2010-03-03       Impact factor: 3.909

5.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

6.  Two types of lateral extension in juvenile nasopharyngeal angiofibroma: diagnostic and therapeutic management.

Authors:  Anna Szymańska; Marcin Szymański; Elżbieta Czekajska-Chehab; Małgorzata Szczerbo-Trojanowska
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-06       Impact factor: 2.503

Review 7.  Endoscopic treatment of esthesioneuroblastoma.

Authors:  Eduardo Machado Rossi Monteiro; Marcelo Guerra Lopes; Emerson Rodrigo Santos; Caroline Valverde Diniz; Aurélia Silva E Albuquerque; Ana Paula de Aquino Ferreira Monteiro; Mauro Becker Martins Vieira
Journal:  Braz J Otorhinolaryngol       Date:  2011 Mar-Apr

8.  Comparison between endoscopic and open surgery in 37 patients with nasopharyngeal angiofibroma.

Authors:  José Alberto Alves Oliveira; Marylane Galvão Tavares; Carolina Veras Aguiar; Jorge Ferreira de Azevedo; João Renato F Sousa; Paulo César de Almeida; Erika Ferreira Gomes
Journal:  Braz J Otorhinolaryngol       Date:  2012-02

9.  Complications in the endoscopic and endoscopic-assisted treatment of juvenile nasopharyngeal angiofibroma with intracranial extension.

Authors:  Maria Dantas Costa Lima Godoy; Thiago Freire Pinto Bezerra; Fabio de Rezende Pinna; Richard Louis Voegels
Journal:  Braz J Otorhinolaryngol       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.